ACCIUM BIOSCIENCES
Developer of an ultrasensitive detection platform designed to overcome challenges faced in clinical development of novel drugs. The company's ultrasensitive detection platform investigates pharmacologic and pharmacodynamic endpoints of Merck's Temodar® in glioblastoma multiforme (GBM) patients, providing 14C-methylation measurements of tumor DNA after 14C-Temodar® administration. The purpose of the study is to identify pharmacologic or pharmacodynamic endpoints that may be predictive of response to therapy in individual patients, enabling clinicians to involve therapeutic response prediction and resistance to treatment.
ACCIUM BIOSCIENCES
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2004-05-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.acciumbio.com
Total Employee:
11+
Status:
Active
Contact:
206.258.8860
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS GoDaddy SSL IIS 8
Similar Organizations
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Investors List
WRF Capital
WRF Capital investment in Seed Round - Accium BioSciences
Official Site Inspections
http://www.acciumbio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
